| Tên sản phẩm | MariTide |
|---|---|
| Số CAS | 2760218-55-9 |
| Từ đồng nghĩa | MARITIDE; GLP-1/Glucagon receptor agonist; dual incretin agonist |
| Hình thức | Bột màu trắng đến trắng ngà |
| Sự tinh khiết | ≥95% (HPLC) |
| Công thức phân tử | Not disclosed |
| Trọng lượng phân tử | Not disclosed |
| Độ hòa tan | Soluble in water and DMSO |
| Lưu trữ | Store at -20°C, protect from light |
| Gói | 5 g, 10 g, 50 g, or custom |
Cần trợ giúp? Liên hệ với đội ngũ của chúng tôi
Synonyms: MARITIDE; GLP-1/Glucagon receptor agonist; dual incretin agonist
MariTide is a synthetic peptide dual agonist designed to activate both the glucagon-like peptide-1 (GLP-1) and glucagon receptors.
This investigational compound is being developed for the treatment of metabolic disorders, including obesity and type 2 diabetes.
Its dual mechanism of action aims to enhance glucose-dependent insulin secretion while promoting energy expenditure through glucagon receptor activation, offering a promising approach to weight management and glycemic control.
MariTide is a synthetic peptide with a molecular structure that includes a fatty acid moiety for prolonged half-life, similar to other incretin-based therapies. The peptide is composed of amino acids that confer resistance to enzymatic degradation, enhancing its in vivo stability. Its exact sequence and modifications are proprietary, but the compound is supplied as a lyophilized powder with high purity.
280 Phố Chính, Tây An, Thiểm Tây, Trung Quốc
English English 
Russian
French
Korean
German
Polish
Japanese
Spanish
Italian
Vietnamese
